Supplementary Methods from OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients
Brendan D. Curti,Magdalena Kovacsovics-Bankowski,Nicholas Morris,Edwin Walker,Lana Chisholm, Kevin Floyd,Joshua Walker, Iliana Gonzalez, Tanisha Meeuwsen,Bernard A. Fox,Tarsem Moudgil,William Miller,Daniel Haley,Todd Coffey,Brenda Fisher, Laurie Delanty-Miller, Nicole Rymarchyk,Tracy Kelly,Todd Crocenzi, Eric Bernstein, Rachel Sanborn,Walter J. Urba,Andrew D. Weinberg crossref（2023）
摘要
PDF file - 68K, Details clinical trial, flow cytometry and monkey experiments referred to in the manuscript.
查看译文
AI 理解论文
溯源树
样例
